1 ASX 300 stock just upgraded by brokers (and 2 downgraded)

Here's the latest ratings changes.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX 300 stocks continue to lift and are showing strength after the US Presidential election concluded overnight.

The S&P/ASX 300 Index (ASX: XKO) is up less than half a percent from the open on Thursday morning, extending this year's gains to above 8%.

However, not all stocks in the index behave in the same way, and brokers have changed their ratings on several ASX 300 stocks.

And not all ratings are made equal. Brokers have made downgrades to Harvey Norman Holdings Ltd (ASX: HVN) and Domain Holdings Australia Ltd (ASX: DHG), but upgraded James Hardie Industries (ASX: JHX) in the same stroke of the pen.

Let's take stock of the latest changes.

Male building supervisor stands and smiles with his arms crossed at a building site with workers behind him.

Image source: Getty Images

ASX 300 shares downgraded

ASX 300 stock Harvey Norman was cut to a sell from Goldman Sachs in a note to clients yesterday. Previously, it rated the share a hold.

Goldman has concerns over Harvey Norman's potential market share loss in a "challenged" retail environment. For this same reason, retail stocks were hammered in H2 of 2024.

The broker has also lowered its target price by 11%, now valuing the ASX 300 share at $4 apiece.

It also noted that Harvey Norman's competitors appear to be capitalising on market share gains, especially in electronics and tech, thereby eating the company's lunch.

Goldman also revised its FY25 forecasts for the retail giant, anticipating sales of $4.13 billion and pre-tax earnings of $628 million – both of which are below consensus.

The broker also reduced valuation multiples on its Australian and New Zealand franchises, along with an increase in the property cap rate.

Domain sliced to hold

Bell Potter also downgraded Domain Holdings to a hold, trimming its target price to $3.20 in the process.

Bell joins colleagues at Goldman Sachs, who reiterated their rating on the ASX 300 stock as a hold in a note to clients overnight.

The broker's outlook hinges on concerns over Domain's growth despite the company projecting 3-5% listings growth for FY25.

Domain's Q1 performance also saw an 8% rise in listing volumes, surpassing competitor REA Group Ltd (ASX: REA).

But Goldman warns this growth may wane in the second half.

It sees downside risks due to increased free listings, which could potentially dilute future yield growth for the company. It values the ASX 300 stock at $2.87, below Bell Potter's valuation.

The Bright Spot: James Hardie

In contrast, James Hardie received an upgrade from JP Morgan, which raised its rating to overweight – analogous to a buy call.

According to The Australian, it raised the stock to a buy with a price target of $55, about 13% above where the ASX 300 stock currently trades.

Goldman Sachs also confirmed James Hardie as a buy in an October note.

The broker revised its earnings estimates slightly lower but remains confident in James Hardie's long-term prospects, largely due to its focus on premium products within the building materials sector.

We revise our estimates ahead of JHX's 2Q25 results in November to reflect recent input cost data. We lower our FY25e Adj NPAT -2% to US$653m towards the lower end of management's US$630-700m guidance range.

We lower our 12m [price target] to A$55.00 from A$55.85. We do not view these changes as material, and there is no change to our investment view. Retain Buy

ASX 300 stock takeaway

While Harvey Norman and Domain Holdings are facing headwinds, brokers are bullish on James Hardie's potential.

However, the fate of these ASX 300 stocks ultimately comes down to the returns of the underlying companies.

Time will tell what eventuates from here.

JPMorgan Chase is an advertising partner of Motley Fool Money. Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, JPMorgan Chase, and REA Group. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool Australia has recommended REA Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on CBA shares

A leading analyst forecasts headwinds for CBA shares. But why?

Read more »

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Broker reiterates buy ratings on 2 ASX shares

These ASX shares remain worth watching.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

After more than quadrupling investors' money in a year, are PLS shares still a buy?

A leading analyst delivers his outlook for the soaring PLS share price.

Read more »

A young man wearing a bright yellow jumper and glasses purses his lips together and moves them to the side of his face as he wonders about something.
Broker Notes

Buy, hold, or sell? Life360, Iress, Lynas Rare Earths shares

Experts reveal their views.

Read more »